Answers are grounded in this paper and cite their sources.
Prospective randomized study shows that transdermal buprenorphine effectively reduces postoperative pain, indicating it is safe for abdominal surgeries.
Background: Effective postoperative pain control enhances recovery and patient satisfaction. Buprenorphine, a partial μ-opioid receptor agonist, is known for its potent analgesia and favorable safety profile. Aim: To evaluate the analgesic efficacy, sedation, hemodynamic impact, and safety of transdermal buprenorphine patches in abdominal surgery patients. Methods: A prospective randomized study included patients undergoing abdominal surgeries who received 10 mcg/hr or 20 mcg/hr transdermal buprenorphine patches applied 6 hours preoperatively. Parameters recorded included heart rate, blood pressure, respiratory rate, SpO₂, VAS, Ramsay sedation scores, and rescue analgesic requirements. Results: Buprenorphine patches provided effective analgesia with stable hemodynamics and minimal adverse effects. The 20 mcg/hr group had significantly lower VAS scores and required fewer rescue analgesics. Conclusion: Transdermal buprenorphine offers a safe, effective alternative for managing postoperative pain in abdominal surgeries.
No takes yet. Share an insight, caveat, or question.
Yadav et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: